The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
123407602 12340760 2 F 20130727 20160722 20160506 20160729 PER US-ELI_LILLY_AND_COMPANY-US201605001687 ELI LILLY AND CO 51.26 YR M Y 120.18000 KG 20160729 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
123407602 12340760 1 PS AXIRON TESTOSTERONE 1 Unknown UNK UNK, QD N U 22504 ORAL LIQUID QD
123407602 12340760 2 SS AXIRON TESTOSTERONE 1 Topical 60 MG, QD N U 22504 60 MG ORAL LIQUID QD
123407602 12340760 3 SS FORTESTA TESTOSTERONE 1 Topical 40 MG, QD U U 0 40 MG QD
123407602 12340760 4 SS FORTESTA TESTOSTERONE 1 Unknown 60 MG, QD U U 0 60 MG QD
123407602 12340760 5 SS TESTOSTERONE CYPIONATE. TESTOSTERONE CYPIONATE 1 Intramuscular UNK UNK, 2/M U U 0
123407602 12340760 6 SS TESTOSTERONE CYPIONATE. TESTOSTERONE CYPIONATE 1 Intramuscular 200 MG, MONTHLY (1/M) U U 0 200 MG /month
123407602 12340760 7 SS TESTOSTERONE CYPIONATE. TESTOSTERONE CYPIONATE 1 Intramuscular 300 MG, MONTHLY (1/M) U U 0 300 MG /month
123407602 12340760 8 SS TESTOSTERONE CYPIONATE. TESTOSTERONE CYPIONATE 1 Intramuscular 200 MG, EVERY 3 WEEKS U U 0 200 MG
123407602 12340760 9 C AZILECT RASAGILINE MESYLATE 1 Oral 1 MG, QD 0 1 MG TABLET QD
123407602 12340760 10 C CLONAZEPAM. CLONAZEPAM 1 Oral 6 MG, EACH EVENING 0 6 MG TABLET QD
123407602 12340760 11 C FISH OIL FISH OIL 1 Oral 2000 MG, QD U 0 2000 MG CAPSULE QD
123407602 12340760 12 C METFORMIN METFORMIN HYDROCHLORIDE 1 Oral 500 MG, BID 0 500 MG TABLET BID
123407602 12340760 13 C NEXIUM ESOMEPRAZOLE MAGNESIUM 1 Oral 40 MG, QD 0 40 MG TABLET QD
123407602 12340760 14 C LASIX FUROSEMIDE 1 Oral UNK UNK, PRN 0 TABLET

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
123407602 12340760 1 Androgen replacement therapy
123407602 12340760 2 Hypogonadism
123407602 12340760 3 Androgen replacement therapy
123407602 12340760 4 Hypogonadism
123407602 12340760 5 Androgen replacement therapy
123407602 12340760 6 Hypogonadism
123407602 12340760 9 Parkinson's disease
123407602 12340760 10 Tourette's disorder
123407602 12340760 12 Diabetes mellitus
123407602 12340760 13 Gastrooesophageal reflux disease
123407602 12340760 14 Fluid retention

Outcome of event

Event ID CASEID OUTC COD
123407602 12340760 HO
123407602 12340760 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
123407602 12340760 Deep vein thrombosis
123407602 12340760 Thrombophlebitis superficial

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
123407602 12340760 1 2012 20140205 0
123407602 12340760 3 20130725 0
123407602 12340760 4 20131029 0
123407602 12340760 5 20120724 0
123407602 12340760 7 20121203 0
123407602 12340760 10 1985 0
123407602 12340760 12 2010 0
123407602 12340760 13 2012 0
123407602 12340760 14 2012 0